covid-19. Use this code when COVID-19 has been confirmed by laboratory testing irrespective of severity of clinical signs or symptoms. Use additional code, if desired, to identify pneumonia or other manifestations.
Conditions
Interventions
Intervention 1: Intervention Group: "Consumption of Iranian Oral Vitamin A in the name of Ovigel Company 200,000 units today and repeat it tomorrow and then control the clinical and laboratory symptom
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to No maximum
Inclusion criteria
Inclusion criteria: All adult patients were hospitalized with covid_19 who were hospitalized for at least the first three days
Exclusion criteria
Exclusion criteria: Pregnant women who with high cerebrospinal fluid pressure People with malnutrition (celiac disease, short bowel syndrome, chronic pancreatitis, and impaired fat and anti-obesity and bariatric surgery)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of O2 saturation. Timepoint: 1-3-5-7-10-14. Method of measurement: PCR, CT scan and clinical symptoms.;Clinical symptoms. Timepoint: 1-3-5-7-10-14. Method of measurement: PCR, CT scan and clinical symptoms. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Farhadifard
Ghoum University of Medical Sciences
Outcome results
None listed